Tikun Olam-Cannbit Pharmaceuticals Ltd

TASE:TKUN 株式レポート

時価総額:₪27.4m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Tikun Olam-Cannbit Pharmaceuticals マネジメント

マネジメント 基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Yifat Karib

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間4.1yrs
CEOの所有権n/a
経営陣の平均在職期間データなし
取締役会の平均在任期間4.8yrs

経営陣の近況

Recent updates

Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Has Debt But No Earnings; Should You Worry?

Jun 21
Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Has Debt But No Earnings; Should You Worry?

Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Apr 28
Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Risks To Shareholder Returns Are Elevated At These Prices For Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)

Jul 21
Risks To Shareholder Returns Are Elevated At These Prices For Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)

Would Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Be Better Off With Less Debt?

Oct 03
Would Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Be Better Off With Less Debt?

Is Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Weighed On By Its Debt Load?

Jun 03
Is Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Weighed On By Its Debt Load?

Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Is Carrying A Fair Bit Of Debt

Oct 17
Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Is Carrying A Fair Bit Of Debt

Is Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Using Debt Sensibly?

May 19
Is Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Using Debt Sensibly?

Shareholders Of Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Must Be Happy With Their 135% Total Return

Mar 19
Shareholders Of Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Must Be Happy With Their 135% Total Return

How Much Did Tikun Olam - Cannbit Pharmaceuticals'(TLV:TKUN) Shareholders Earn From Share Price Movements Over The Last Five Years?

Dec 02
How Much Did Tikun Olam - Cannbit Pharmaceuticals'(TLV:TKUN) Shareholders Earn From Share Price Movements Over The Last Five Years?

CEO報酬分析

Tikun Olam-Cannbit Pharmaceuticals の収益と比較して、Yifat Karib の報酬はどのように変化したか?
日付総報酬給与会社業績
Dec 31 2023n/an/a

-₪89m

Sep 30 2023n/an/a

-₪98m

Jun 30 2023n/an/a

-₪107m

Mar 31 2023n/an/a

-₪77m

Dec 31 2022₪674k₪582k

-₪48m

Sep 30 2022n/an/a

-₪38m

Jun 30 2022n/an/a

-₪27m

Mar 31 2022n/an/a

-₪30m

Dec 31 2021₪850k₪565k

-₪33m

報酬と市場: Yifatの 総報酬 がIL市場の同規模の企業と比較して妥当かどうかを判断するにはデータが不十分です。

報酬と収益: Yifatの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Yifat Karib (51 yo)

4.1yrs

在職期間

₪674,000

報酬

Ms. Yifat Karib is CEO from March 27, 2023, VP of Marketing & Government Relations from June 01, 2020 at Tikun Olam-Cannbit Pharmaceuticals Ltd respectively.


取締役

名称ポジション在職期間報酬所有権
Erez Navon
Director5.1yrsデータなし2.7%
₪ 739.5k
Eitan Eliyahu
Chairman of the Board5.1yrs₪505.00kデータなし
Yaron Naor
Director5.1yrsデータなし10.51%
₪ 2.9m
Yitzhak Ashkenazi
Independent Director4.8yrsデータなし0.060%
₪ 16.5k
Orly Zilberman
Independent External Director3.3yrsデータなしデータなし
Ellit Mann Bitton
Independent External Director2.9yrsデータなしデータなし
Adi Zvulun
Director1.8yrsデータなしデータなし

4.8yrs

平均在職期間

54yo

平均年齢

経験豊富なボード: TKUNの 取締役会経験豊富 であると考えられます ( 4.7年の平均在任期間)。